Help Continue Groundbreaking Research on Caffeine

London, Greater London, United Kingdom

Help Continue Groundbreaking Research on Caffeine

£285

raised so far

We are raising funds


Crowdfunder is secure

Your payment details are protected


Always on

This project successfully funded on 31st December 2025, you can still support them with a donation.

Aim

☕ “Your daily coffee could hold the key to better health — help uncover what caffeine really does inside the body.”


Support Groundbreaking Research on Caffeine and AMPK Regulation

By Dr. John-Patrick Alao, PhD, FHEA, CSci, MRSB

Hello, my name is Dr. John-Patrick Alao, and I am a biochemist and molecular biologist with over 20 years of experience in academic and biomedical research. I have held positions at Imperial College London, Gothenburg University (Sweden), University of East London, and University of Essex/Queen Mary University of London. My work has focused on the molecular mechanisms of cancer, cell cycle regulation, and metabolic control — with over 2,500 citations and publications in leading journals such as Cells, Microbial Cell, and Molecular Cancer.

My recent and ongoing research investigates how caffeine interacts with AMPK (AMP-activated protein kinase) — a central energy-sensing enzyme that regulates metabolism, aging, and stress resistance. Understanding this relationship could shed light on how dietary components like caffeine influence longevity, cellular health, and cancer susceptibility.

Unfortunately, short-term academic contracts and research funding gaps make it challenging to maintain momentum in independent projects like this. I am therefore seeking crowdfunding to cover basic living and research expenses for one year, allowing me to continue this important work without interruption.

Funding Goal

 £35,000


 This support will enable me to:

  • Continue my independent biochemical research on caffeine–AMPK signaling.
  • Cover essential living expenses to sustain full-time research activity.
  • Share results openly through preprints, seminars, and public science communication.

Why It Matters

AMPK is a major target in metabolic diseases, neurodegeneration, and cancer. Understanding how common dietary molecules like caffeine affect AMPK may contribute to:

  • Improved dietary guidelines for metabolic and neurological health.
  • New insights into aging and energy balance.
  • Translational applications in drug discovery and health optimization.

How You Can Help

Every contribution — large or small — directly supports continued independent research into a promising and underexplored area of science.
 If you believe in evidence-based nutrition, open science, and independent biomedical inquiry, your support can make a real difference.

Thank you for helping me continue this journey of discovery.

Dr. John-Patrick Alao, PhD, FHEA, CSci, MRSB
Email: [email protected]
 ORCID: 0000-0002-128-8560


Funding method

Keep what you raise – this project will receive all pledges made


Show your support

Payment and personal details are protected